Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

NCT03199560 PHASE4 UNKNOWN

A randomized controlled double-blinded study comparing the intraoperative injection of lymphatic mapping agents Tc 99m tilmanocept to Tc 99m filtered sulfur colloid in breast cancer patients undergoing breast conservation and sentinel lymph node biopsy

Details

Lead sponsor	Memorial Health University Medical Center
Phase	PHASE4
Status	UNKNOWN
Enrolment	86
Start date	Thu Jun 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Aug 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Sentinel Lymph Node Biopsy
• Breast Cancer

Interventions

• Tc 99m tilmanocept
• Tc 99m filtered sulfur colloid

Countries

United States